DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,029,013 | -5.5% | 4,685 | +3.3% | 0.03% | 0.0% |
| Q2 2023 | $1,088,880 | +14.6% | 4,537 | +20.3% | 0.03% | +10.7% |
| Q1 2023 | $950,191 | +110774.1% | 3,770 | +16.8% | 0.03% | +16.7% |
| Q4 2022 | $857 | -99.9% | 3,229 | +36.1% | 0.02% | +26.3% |
| Q3 2022 | $613,000 | -53.8% | 2,372 | -54.7% | 0.02% | -54.8% |
| Q2 2022 | $1,327,000 | -55.3% | 5,235 | -48.3% | 0.04% | -50.0% |
| Q1 2022 | $2,971,000 | -12.6% | 10,128 | -2.0% | 0.08% | -16.0% |
| Q4 2021 | $3,399,000 | +10.6% | 10,331 | +2.3% | 0.10% | +25.0% |
| Q3 2021 | $3,074,000 | +12.1% | 10,098 | -1.1% | 0.08% | -2.4% |
| Q2 2021 | $2,741,000 | -18.4% | 10,215 | -31.6% | 0.08% | -33.3% |
| Q1 2021 | $3,361,000 | +19.2% | 14,932 | +14.1% | 0.12% | +21.8% |
| Q3 2020 | $2,819,000 | -41.4% | 13,092 | -51.9% | 0.10% | -14.4% |
| Q2 2020 | $4,808,000 | +393.1% | 27,192 | +286.1% | 0.12% | +145.8% |
| Q1 2020 | $975,000 | +10.9% | 7,043 | +23.0% | 0.05% | +23.1% |
| Q4 2019 | $879,000 | +29.5% | 5,724 | +21.8% | 0.04% | +39.3% |
| Q3 2019 | $679,000 | -51.2% | 4,701 | -51.7% | 0.03% | -28.2% |
| Q2 2019 | $1,392,000 | -52.5% | 9,739 | -56.2% | 0.04% | -62.9% |
| Q1 2019 | $2,932,000 | +56.6% | 22,210 | +22.3% | 0.10% | +10.5% |
| Q4 2018 | $1,872,000 | +6.5% | 18,157 | +12.3% | 0.10% | +61.0% |
| Q3 2018 | $1,757,000 | -10.4% | 16,169 | -18.6% | 0.06% | -30.6% |
| Q2 2018 | $1,961,000 | +15.5% | 19,868 | +14.5% | 0.08% | +14.9% |
| Q1 2018 | $1,698,000 | +32.7% | 17,347 | +12.2% | 0.07% | -7.5% |
| Q4 2017 | $1,280,000 | +83.9% | 15,457 | +84.1% | 0.08% | +100.0% |
| Q3 2017 | $696,000 | +7.4% | 8,397 | +7.3% | 0.04% | +2.6% |
| Q2 2017 | $648,000 | -2.8% | 7,828 | +0.4% | 0.04% | -11.4% |
| Q1 2017 | $667,000 | -21.3% | 7,800 | -28.4% | 0.04% | -24.1% |
| Q4 2016 | $847,000 | – | 10,887 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |